Synovial Sarcoma, X Breakpoint 2B (SSX2B) (C-Term) anticorps
Aperçu rapide pour Synovial Sarcoma, X Breakpoint 2B (SSX2B) (C-Term) anticorps (ABIN3187724)
Antigène
Voir toutes Synovial Sarcoma, X Breakpoint 2B (SSX2B) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- SSX Polyclonal Antibody detects endogenous levels of SSX protein.
-
Attributs du produit
- Rabbit Polyclonal to SSX.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from the C-terminal region of human SSX.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000, IHC-P 1:100-300, ELISA 1:20000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C.
-
-
- Synovial Sarcoma, X Breakpoint 2B (SSX2B)
-
Autre désignation
- SSX
-
Poids moléculaire
- 21931 kDa,21620 kDa,21697 kDa,21858 kDa,21660 kDa,21688 kDa,21591 kDa,21859 kDa,21553 kDa (different Isoforms)
-
ID gène
- 6756
-
UniProt
- Q16384
Antigène
-